Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records
- PMID: 30649734
- PMCID: PMC6842570
- DOI: 10.1007/s40264-018-0766-8
Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records
Conflict of interest statement
Conflicts of Interest
Feifan Liu has no conflicts of interest that are directly relevant to the content of this study.
Abhyuday Jagannatha has no conflicts of interest that are directly relevant to the content of this study.
Hong Yu has no conflicts of interest that are directly relevant to the content of this study.
References
-
- Coloma PM, Trifirò G, Patadia V, Sturkenboom M. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture? Drug Saf 2013;36:183–97. - PubMed
-
- Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA: the journal of the American Medical Association 1997;277:307. - PubMed
-
- Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005;165:1111–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
